Detalhe da pesquisa
1.
Endothelial Activation and Stress Index in adults undergoing allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide-based prophylaxis.
Cytotherapy
; 26(1): 73-80, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37952139
2.
Impact of letermovir prophylaxis in CMV reactivation and disease after allogenic hematopoietic cell transplantation: a real-world, observational study.
Ann Hematol
; 103(2): 609-621, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37957371
3.
Post-Transplantation Cyclophosphamide and Tacrolimus for Graft-versus-Host Disease Prevention after Allogeneic Hematopoietic Cell Transplantation from HLA-Matched Donors Has More Advantages Than Limitations.
Transplant Cell Ther
; 30(2): 213.e1-213.e12, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38042256
4.
Easix Score Correlates With Endothelial Dysfunction Biomarkers and Predicts Risk of Acute Graft-Versus-Host Disease After Allogeneic Transplantation.
Transplant Cell Ther
; 30(2): 187.e1-187.e12, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38000709
5.
EASIX and cardiac adverse events after allogeneic hematopoietic cell transplantation.
Bone Marrow Transplant
; 2024 Mar 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38521885
6.
Applicability and validation of different prognostic scores in allogeneic hematopoietic cell transplant (HCT) in the post-transplant cyclophosphamide era.
Hematol Transfus Cell Ther
; 2023 Oct 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37891074
7.
Effect of CD34+ Cell Dose on the Outcomes of Allogeneic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide.
Transplant Cell Ther
; 29(3): 181.e1-181.e10, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36526259
8.
Incidence, risk factors, and impact of early cardiac toxicity after allogeneic hematopoietic cell transplant.
Blood Adv
; 7(10): 2018-2031, 2023 05 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36453637
9.
An endothelial proinflammatory phenotype precedes the development of the engraftment syndrome after autologous Hct.
Bone Marrow Transplant
; 57(5): 721-728, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35184147
10.
PTCY and Tacrolimus for GVHD Prevention for Older Adults Undergoing HLA-Matched Sibling and Unrelated Donor AlloHCT.
Transplant Cell Ther
; 28(8): 489.e1-489.e9, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35577323
11.
Bacterial Bloodstream Infections in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide.
Transplant Cell Ther
; 28(12): 850.e1-850.e10, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36089250
12.
Impact of severe acute kidney injury and chronic kidney disease on allogeneic hematopoietic cell transplant recipients: a retrospective single center analysis.
Bone Marrow Transplant
; 55(7): 1264-1271, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32103146
13.
Improving security of autologous hematopoietic stem cell transplant in patients with light-chain amyloidosis.
Bone Marrow Transplant
; 54(8): 1295-1303, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30664727
14.
Hyponatremia induced by post-transplant cyclophosphamide in allogeneic hematopoietic cell transplantation.
Bone Marrow Transplant
; 58(2): 212-214, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36335256